Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors α and δ
BARRY MARC FORMAN, Jasmine Chen, Ronald M. Evans · Proceedings of the National Academy of Sciences · 1997
Fatty acids (FAs) and their derivatives are essential cellular metabolites whose concentrations must be closely regulated. This implies that regulatory circuits exist which can sense changes in FA levels. Indeed, the peroxisome proliferator-activated receptor alpha (PPARalpha) regulates lipid homeostasis and is transcriptionally activated by a variety of lipid-like compounds. It remains unclear as to how these structurally diverse compounds can activate a single receptor. We have developed a novel conformation-based assay that screens activators for their ability to bind to PPARalpha/delta and induce DNA binding. We show here that specific FAs, eicosanoids, and hypolipidemic drugs are ligands for PPARalpha or PPARdelta. Because altered FA levels are associated with obesity, atherosclerosis, hypertension, and diabetes, PPARs may serve as molecular sensors that are central to the development and treatment of these metabolic disorders.
Cited by 2,115 works. doi:10.1073/pnas.94.9.4312
Authors
References
- Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators
- 15-Deoxy-Δ12,14-Prostaglandin J2 is a ligand for the adipocyte determination factor PPARγ
- A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor γ and promotes adipocyte differentiation
- The RXR heterodimers and orphan receptors
- Differential expression and activation of a family of murine peroxisome proliferator-activated receptors.
- Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors
- Fatty acids activate a chimera of the clofibric acid-activated receptor and the glucocorticoid receptor.
- Targeted Disruption of the α Isoform of the Peroxisome Proliferator-Activated Receptor Gene in Mice Results in Abolishment of the Pleiotropic Effects of Peroxisome Proliferators
- The PPARα–leukotriene B4 pathway to inflammation control
- Identification of a nuclear receptor that is activated by farnesol metabolites